FindTrial
Sign In

Exploring the role of blood clotting pathway in patients with severe COVID-19 infection.

Exploring the role of hemostatic pathway in patients with severe SARS CoV-2 infection â?? A prospective proof of concept study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/04/032793
Enrollment
100
Registered
2021-04-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Christian Medical College Vellore
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Evidence of SARS CoV 2 infection diagnosed by a RT-PCR. Fulfill WHO classification of severity of infection.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Determine the presence of a hypercoagulable state in SARS CoV2 infection. Timepoint: Baseline, 5 days—

Secondary

MeasureTime frame
Hospital and ICU mortalityTimepoint: Discharge/Death;Occurrence of any documented thrombotic events â?? Pulmonary embolism, Acute coronary syndrome, cerebrovascular accidents, venous thromboembolism, mesenteric ischemia etcTimepoint: Baseline, Discharge/Death;Ventilator free daysTimepoint: Discharge/Death—

Countries

India

Contacts

Public ContactManoj Job S B

Christian Medical College

drmanojjob@gmail.com9489663692

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026